Additionally, mutational signatures associated with MMR have been found to be enriched in breast cancer brain metastases compared to primary breast tumors [45], suggesting that there may be a role of MMR and PD-L1 testing in metastatic breast cancer specimens. Here, MRC1 is linked to breast neoplasm.